ANL Stock Analysis: Buy, Sell, or Hold?
$10.63
4.10 (62.79%)
▲
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
25d
Get Alerted When ANL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called ANL this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ANL is 146.6% above fair value ($4.31). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ANL is 146.6% above fair value ($4.31). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ANL is currently trading at $10.63, which is considered extended relative to its 30-day fair value range of $0.42 to $4.31.
Technical Outlook: Technically, ANL is showing sideways momentum. The price is approaching resistance at $10.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 62.8% recently.
Market Sentiment: ANL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+37.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ANL is showing sideways momentum. The price is approaching resistance at $10.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 62.8% recently.
Market Sentiment: ANL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+37.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.42 -
$4.31
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
ANL is technically overbought (RSI 96). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+146.6% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+62.8%)
- BULLISH: Trading 37.8% below Wall St target ($9.00)
- WARNING: Recommendation downgraded due to 146.6% overvaluation
Fair Price Analysis
30-Day Fair Range
$0.42 -
$4.31
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.63
Resistance Level
$10.15
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-18.14
Wall Street Target
$9.00
(+37.8%)
Revenue Growth (YoY)
118.0%
Last updated: January 30, 2026 4:03 PM ET
Data refreshes hourly during market hours. Next update: 5:03 PM
Data refreshes hourly during market hours. Next update: 5:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANL showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 55 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
Advanced ANL Option Strategies
Professional options setups generated by AI based on today's ANL price and gamma walls.